Topline Results

BioVie Inc., (NASDAQ: BIVI) a clinical-stage company developing innovative drug therapies for the treatment of advanced liver disease and neurological and neurodegenerative disorders, announced Topline Results from an Investigator-Sponsored Phase 2 clinical trial of NE3107 for the treatment of Alzheimer’s Disease. Updates from other BioVie trials underway are also provided.